ArticleAntiviral research2021

SARS-CoV-2 monoclonal antibodies with therapeutic potential: Broad neutralizing activity and No evidence of antibody-dependent enhancement.

Ying-Ting Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.